Follow
SynAct Pharma AB
Spotlight (Sweden)
SynAct Pharma is a pharmaceutical group that conducts research and development in the treatment of inflammatory diseases. The company has developed a platform technology that is aimed at severe conditions in chronic inflammatory diseases, and foremost joint injuries. The subsidiary SynAct Pharma Aps was initially founded in 2012 and the parent company was established in 2016. The head office is located in Lund.
Sector:
HEALTH CARE
New issue
Price
6.20 SEK
Subscription period
18 Nov - 02 Dec 2019
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
SYNACT
SE0008241491
Spotlight
Sweden (SE)
Details of share in SynAct Pharma AB with ticker SYNACT
Status
Active
Order book id
4144
Amount of instruments
14 675 167
Par value
0.1250
Market cap
Currency
SEK
First trading date
11 Jul 2016
Terms
Type
Price
Pre-money valuation
Time
IPO
6.40 SEK
46.1M SEK
24 May - 08 Jun 2016
IPO in SynAct Pharma AB
Market
Spotlight
Subscription period
24 May - 08 Jun 2016
Subscription price
32.00 SEK
Price per share
6.40 SEK
Target to raise
32 320 000 SEK
Types
Pre-money valuation
46 100 000 SEK
Subscription block size
Minimum subscription
150
Record date
Offer status
Closed
Listing status
Listed
First trading date
11 Jul 2016
Issue terms
Targeted to the public and institutions.
Type
Price
Pre-money valuation
Time
Exercise
6.40 SEK
-
09 Mar - 23 Mar 2017
Option exercise terms for SYNACT TO 1
Market
Spotlight
Exercise period(s)
09 Mar - 23 Mar 2017
Exercise price
6.40 SEK
Status
Closed
Issue terms
Type
Price
Pre-money valuation
Time
New issue
9.90 SEK
122.9M SEK
19 Apr - 08 May 2018
Share issue in SynAct Pharma AB
Market
Spotlight
Subscription period
19 Apr - 08 May 2018
Subscription price
Price per share
9.90 SEK
Target to raise
22 351 000 SEK
Types
Share issue
Pre-money valuation
122 900 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Preferential right 2:11. For each existing share one (1) subscription right is obtained. The holding of eleven (11) subscription rights entitles the holder to subscribe for two (2) new shares.
Type
Price
Pre-money valuation
Time
New issue
6.20 SEK
91M SEK
18 Nov - 02 Dec 2019
Share issue in SynAct Pharma AB
Market
Spotlight
Subscription period
18 Nov - 02 Dec 2019
Subscription price
24.80 SEK
Price per share
6.20 SEK
Target to raise
17 300 000 SEK
Types
Share issue
Pre-money valuation
91 000 000 SEK
Subscription block size
Minimum subscription
Record date
13 Nov 2019
Offer status
Active
Listing status
Listed
Issue terms
Twenty one (21) unit rights entitles to subscribe for one (1) new unit. One (1) unit consists of four (4) shares and four (4) warrants of series TO 2. The warrants are issued free of charge.
Comments for offer & related information
Type
Ticker
ISIN
Market
OPTION
SYNACT TO 2
SE0013409620
Spotlight
Sweden (SE)
Details of option in SynAct Pharma AB with ticker SYNACT TO 2
Status
Active
Order book id
Amount of instruments
4 891 268
Market cap
Currency
SEK
First trading date
Terms
Each subscription option of series TO 2 entitles to subscribe for a new share.
Type
Price
Pre-money valuation
Time
Exercise
6.70 SEK
-
01 Jul - 22 Jul 2020
Option exercise terms for SYNACT TO 2
Market
Spotlight
Exercise period(s)
01 Jul - 22 Jul 2020
Exercise price
6.70 SEK
Status
Upcoming
Issue terms
Each subscription option of series TO 2 entitles to subscribe for a new share.
Type
Ticker
ISIN
Market
SHARE
SYNACT
SE0008241491
Spotlight
Sweden (SE)
Details of share in SynAct Pharma AB with ticker SYNACT
Status
Active
Order book id
4144
Amount of instruments
14 675 167
Par value
0.1250
Market cap
Currency
SEK
First trading date
11 Jul 2016
Terms
Type
Price
Pre-money valuation
Time
IPO
6.40 SEK
46.1M SEK
24 May - 08 Jun 2016
IPO in SynAct Pharma AB
Market
Spotlight
Subscription period
24 May - 08 Jun 2016
Subscription price
32.00 SEK
Price per share
6.40 SEK
Target to raise
32 320 000 SEK
Types
Pre-money valuation
46 100 000 SEK
Subscription block size
Minimum subscription
150
Record date
Offer status
Closed
Listing status
Listed
First trading date
11 Jul 2016
Issue terms
Targeted to the public and institutions.
Type
Price
Pre-money valuation
Time
New issue
9.90 SEK
122.9M SEK
19 Apr - 08 May 2018
Share issue in SynAct Pharma AB
Market
Spotlight
Subscription period
19 Apr - 08 May 2018
Subscription price
Price per share
9.90 SEK
Target to raise
22 351 000 SEK
Types
Share issue
Pre-money valuation
122 900 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Preferential right 2:11. For each existing share one (1) subscription right is obtained. The holding of eleven (11) subscription rights entitles the holder to subscribe for two (2) new shares.
Type
Price
Pre-money valuation
Time
New issue
6.20 SEK
91M SEK
18 Nov - 02 Dec 2019
Share issue in SynAct Pharma AB
Market
Spotlight
Subscription period
18 Nov - 02 Dec 2019
Subscription price
24.80 SEK
Price per share
6.20 SEK
Target to raise
17 300 000 SEK
Types
Share issue
Pre-money valuation
91 000 000 SEK
Subscription block size
Minimum subscription
Record date
13 Nov 2019
Offer status
Active
Listing status
Listed
Issue terms
Twenty one (21) unit rights entitles to subscribe for one (1) new unit. One (1) unit consists of four (4) shares and four (4) warrants of series TO 2. The warrants are issued free of charge.
Comments for offer & related information
Type
Ticker
ISIN
Market
OPTION
SYNACT TO 1
SE0008320972
Spotlight
Sweden (SE)
Details of option in SynAct Pharma AB with ticker SYNACT TO 1
Status
Archived
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
Terms
Type
Price
Pre-money valuation
Time
Exercise
6.40 SEK
-
09 Mar - 23 Mar 2017
Option exercise terms for SYNACT TO 1
Market
Spotlight
Exercise period(s)
09 Mar - 23 Mar 2017
Exercise price
6.40 SEK
Status
Closed
Issue terms
Type
Ticker
ISIN
Market
OPTION
SYNACT TO 2
SE0013409620
Spotlight
Sweden (SE)
Details of option in SynAct Pharma AB with ticker SYNACT TO 2
Status
Active
Order book id
Amount of instruments
4 891 268
Market cap
Currency
SEK
First trading date
Terms
Each subscription option of series TO 2 entitles to subscribe for a new share.
Type
Price
Pre-money valuation
Time
Exercise
6.70 SEK
-
01 Jul - 22 Jul 2020
Option exercise terms for SYNACT TO 2
Market
Spotlight
Exercise period(s)
01 Jul - 22 Jul 2020
Exercise price
6.70 SEK
Status
Upcoming
Issue terms
Each subscription option of series TO 2 entitles to subscribe for a new share.
People
Jeppe Øvlesen
CEO
Torbjørn Bjerke
Chairman of the board
John Haurum
Board member
Terje Kalland
Board member
Thomas Jonassen
Board member
Company Details
Sector
HEALTH CARE

Address
C/O Medicon Village Ab
Zip code
223 81
City/district
Lund
Country
Sweden (SE)
Registration number
559058-4826
LEI code
549300RRYIEFEQ72N546
First trade date
11 Jul 2016
Registration date
12 Apr 2016
Short name
SYNACT

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More